Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

The diaTribe team is excited to provide you with the latest news in diabetes research, prevention, care, and technology from the American Diabetes Association 82nd...
Learn about a clinical trial designed to study the long-term effects of the GLP-1 receptor agonist semaglutide on eye health and how to enroll if you are eligible.
Returning to in-person appointments and standard diabetes care can sometimes mean switching your healthcare team to better suit your needs. Here are tips for...
Continuous glucose monitors (CGM) and other advancements in diabetes technology over the past decade have given people with diabetes a greater ability to manage their...
Although there is no cure, more than 60% of people with type 2 diabetes are expected to develop liver disease, it is vital to be screened. Learn about prevention,...
Mounjaro (tirzepatide), a first-of-its kind medication for treating type 2 diabetes, has been approved by the FDA after much anticipation. This new medication has been...
Sports are a great way for people to engage in healthy habits, and they can contribute to positive mental health outcomes as well. Shawn Laib describes the ways...
Diabetes affects the skin in ways people may not even realize. Read about this connection and learn how to maintain healthy skin.
Learn what some of the latest research says about the heart health benefits of diabetes drugs like SGLT-2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs.
As a child of a person with diabetes, it can often feel as though the odds are stacked against you and those you love. Terrisha Buckley shares her experience learning...
At ATTD 2022, researchers discussed the latest research on pregnancy, menstrual cycles, and overall health outcomes in women with diabetes. Diabetes technology can be a...
India is a developing country where diabetes is highly prevalent. Leading endocrinologists shared how they use the messaging service WhatsApp and Professional CGMs to...
In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...
Clinical trial results published by Lilly show that Tirzepatide could potentially be one of the most effective drugs ever developed for weight loss. Experts discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.
Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies.
At ATTD 2022, several researchers presented on projects aimed at understanding and addressing the impact of hypoglycemia. While diabetes technology is helpful and...
The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top...
At the ATTD 2022 conference, diabetes advocates delivered presentations on open-source AID, access to insulin and diabetes supplies, and diabetes stigma in the #dedocº...
At this year’s Advanced Technologies and Treatment conference in Barcelona, diaTribe will bring together dozens of experts in diabetes for a revolutionary consensus...

Pages